Nav: Home

Improved airway-targeted gene delivery in a pig model of cystic fibrosis

September 08, 2016

Cystic fibrosis (CF) is characterized by accumulation of thick mucus in the lungs and is associated with a high incidence of bacterial infection. Mutations in the gene encoding CF transmembrane conductance regulator (CFTR) underlie the disease. Gene therapy to deliver a normal copy of the CFTR gene has shown promise in both pre-clinical models and clinical trials; however, current gene delivery methods are inefficient and do not result in sustained expression of functional CFTR in the airways. Two studies in this issue of JCI Insight report the development and use of viral vector-based delivery of CFTR in pig models of CF. A team led by Patrick Sinn and Paul McCray Jr. of the University of Iowa developed a lentiviral-based vector that was delivered through the nose to newborn CF pigs. Analysis of these animals revealed evidence of functional CFTR expression in the airways. A second team led by Joseph Zabner of the University of Iowa and David Schaffer of the University of California, Berkeley, generated an adeno-associated virus (AAV) that homes to the pig airway to mediate expression of functional CFTR in the airways of 1 week-old CF pigs. Together, these reports indicate that viral vector-based approaches could potentially improve the effectiveness of CFTR gene therapy.

TITLE:

Lentiviral-mediated phenotypic correction of cystic fibrosis pigs

AUTHOR CONTACT:

Paul B. McCray, Jr.
The University of Iowa
Email: paul-mccray@uiowa.edu

Patrick L. Sinn
The University of Iowa
Email: patrick-sinn@uiowa.edu.

View this article at:http://insight.jci.org/articles/view/88730?key=b4689e6b7aedc95452bc

TITLE:

CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes

AUTHOR CONTACT:

Joseph Zabner
University of Iowa Carver College of Medicine
Email:joseph-zabner@uiowa.edu

David Schaffer
University of California, Berkeley
Email: schaffer@berkeley.edu.

View this article at: http://insight.jci.org/articles/view/88728?key=7e8c808d25cd5e3b5597
-end-
JCI Insight is the newest publication from the American Society of Clinical Investigation, a nonprofit honor organization of physician-scientists. JCI Insight is dedicated to publishing a range of translational biomedical research with an emphasis on rigorous experimental methods and data reporting. All articles published in JCI Insight are freely available at the time of publication. For more information about JCI Insight and all of the latest articles go to http://www.insight.jci.org.

JCI Journals

Related Gene Therapy Articles:

Mysterious gene transcripts after cancer therapy
Drugs that are used in cancer therapy to erase epigenetic alterations in cancer cells simultaneously promote the production of countless mysterious gene transcripts, scientists from the German Cancer Research Center now report in Nature Genetics.
Gene therapy could 'turn off' severe allergies
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.
Lipid nanoparticles for gene therapy
Twenty-five years have passed since the publication of the first work on solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as a system for delivering drugs.
New gene therapy for pseudarthrosis trialed at Kazan University
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation.
WSU researcher develops safer gene therapy
A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.
New gene therapy prevents muscle wasting associated with cancer
A new gene therapy could be used to prevent the loss of muscle mass and physical strength associated with advanced cancer
On the path to controlled gene therapy
The ability to switch disease-causing genes on and off remains a dream for many physicians, research scientists and patients.
Gene therapy against brain cancer
A team from the International School for Advanced Studies (SISSA) in Trieste has obtained very promising results by applying gene therapy to glioblastoma.
First gene therapy successful against human aging
Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully rejuvenated by gene therapy, after her own company's experimental therapies reversed 20 years of normal telomere shortening.
Designing gene therapy
Scientists in the Barabas group at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials for leukemia and lymphoma immunotherapies.

Related Gene Therapy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...